RCKT
Rocket Pharmaceuticals Inc
NASDAQ: RCKT · HEALTHCARE · BIOTECHNOLOGY
$3.48
+0.00% today
Updated 2026-04-30
Market cap
$379.93M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.01
Dividend yield
—
52W range
$2 – $8
Volume
3.7M
Rocket Pharmaceuticals Inc (RCKT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-6.94M | $-6.46M | $-9.74M | $-17.42M | $-37.27M | $-26.11M | $-53.79M | $-64.66M | $-74.64M | $-121.16M | $-178.14M | $-194.92M | $-209.72M | $-190.01M |
| Capital expenditures | $0.00 | $0.00 | $412000.00 | $412000.00 | $487000.00 | $70000.00 | $1.45M | $23.27M | $29.06M | $7.71M | $8.62M | $16.47M | $5.86M | $440000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $486000.00 | $-148000.00 | $177000.00 | $2.38M | $2.91M | $4.04M | $13.60M | $13.37M | $18.57M | $29.24M | $31.01M | $39.41M | $43.92M | $37.06M |
| Free cash flow | $-6.94M | $-6.46M | $-10.15M | $-17.83M | $-37.75M | $-26.18M | $-55.24M | $-87.93M | $-103.70M | $-128.88M | $-186.76M | $-211.39M | $-215.59M | $-190.45M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $0.00 | $155000.00 | $0.00 | — | — | $5.56M | — | $172000.00 | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $76.42M | $-50.24M | $48.92M | $94.44M | $74.12M | $111.76M | $-64.63M | — | — | — | — |